1-3 of 3
Jennifer Sun, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) + Utomilumab Patients with Refractory Large B Cell Lymphoma

Ran Reshef, MDMSc, David B. Miklos, MD PhD, John M. Timmerman, MD, Caron A. Jacobson, MD MMSc, Nabila N. Bennani, MD, John M. Rossi, MS, Marika Sherman, MS, Lianqing Zheng, PhD, Jennifer Sun, MS, Gabrielle Palluconi, BS, Jenny J. Kim, MD MS, Michael D. Jain, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4084.
https://doi.org/10.1182/blood-2019-123772
Published: 2019
Journal Articles

A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients with Refractory Large B-Cell Lymphoma (ZUMA-14)

Sattva S Neelapu, MD, Mohamed A Kharfan-Dabaja, MDMBA, Olalekan O. Oluwole, MBBS, MPH, Patel Krish, MD, Ran Reshef, MDMSc, Peter A. Riedell, MD, Parveen Shiraz, MD, Patrick J. Stiff, MD, Jose Villasboas, MD, Lovely Goyal, PhD, Jun Kawashima, Francesca Milletti, PhD, Edward Oliva, Jennifer Sun, MS, Javier Munoz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4093.
https://doi.org/10.1182/blood-2019-126369
Published: 2019
Journal Articles

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma

Caron A. Jacobson, MD MMSc, Frederick L. Locke, MD, David B. Miklos, MD PhD, Alex F. Herrera, MD, Jason R. Westin, MD, Jennifer Lee, John M. Rossi, MS, Lianqing Zheng, PhD, Mauro P. Avanzi, MD, Zachary J. Roberts, MD, PhD, Jennifer Sun, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4192.
https://doi.org/10.1182/blood-2018-99-111523
Published: 2018